Altered inotropic responsiveness and gene expression of hypertrophied myocardium with captopril

Hypertension

Volumn 35, Issue 6, 2000, Pages 1203-1209

  Brooks, Wesley W ^a,d   Bing, Oscar H L ^a   Boluyt, Marvin O ^b   Malhotra, Ashwani ^c   Morgan, James P ^a   Satoh, Naoya ^a   Colucci, Wilson S ^a   Conrad, Chester H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Calcium; Heart failure; Hypertrophy, left ventricular; Receptors, adrenergic, beta

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

EID: 0034045758     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.6.1203     Document Type: Article

References (38)

1. Saragoca M, Tarazi RC. Impaired cardiac contractile response to isoproterenol in the spontaneously hypertensive rat. Hypertension 1981;3: 380-385.
2. Gende OA, Mattiazzi A, Camilion MC, Pedroni P, Taquini C, Gomez Llambi H, Cingolani HE. Renal hypertension impairs inotropic isoproterenol effect without beta-receptor changes. Am J Physiol. 1985;249: H814-H819.
3. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
4. 1-receptor downregulation in heart failure Circ Res. 1986;59:297-309.
5. Atkins FL, Bing OH, DiMauro PG, Conrad CH, Robinson KG, Brooks WW. Modulation of left and right ventricular β-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure. Hypertension. 1995;26:78-82.
6. Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance: plasticity of the myocardium generated through protein isoform switches J Clin Invest. 1989;84:1693-1700.
7. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix components. Circ Res 1994;75: 23-32.
8. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR. Changes in gene expression in the intact human heart: downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997;100: 2315-2324.
9. Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 1997; 100:2362-2370.
10. 2+ exchanger in end-stage human heart failure. Circ Res. 1994;75:443-453.
11. 2+ exchanger in failing human myocardium. Circulation. 1996;94:992-1002.
12. Brooks WW, Bing OH, Conrad CH, O'Neill L, Crow MT, Lakatta EG, Dostal DE, Baker KM, Boluyt MO. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats. Hypertension. 1997;30:1362-1368.
13. Wiesner RJ, Ehmke H, Faulhaber J, Zak R, Ruegg JC. Dissociation of left ventricular hypertrophy, β-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation. 1997;95:1253-1259.
14. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci U S A. 1982;79:3310-3314.
15. Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. Circulation. 1997;96: 4002-4010.
16. Bing OH, Brooks WW, Conrad CH, Sen S, Perreault CL, Morgan JP. Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition to heart failure. Circ Res. 1991; 68:1390-1400.
17. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation. 1995;91:161-170.
18. 2+ concentrations in living cells. Prog Biophys Mol Biol. 1982;40:1-114.
19. Brooks WW, Bing OH, Blaustein AS, Allen PD. Comparison of contractile state and myosin isozymes of rat right and left ventricular myocardium. J Mol Cell Cardiol. 1987;19:433-440.
20. Hoh JF, McGrath PA, Hale PT. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J Mol Cell Cardiol. 1978;10:1053-1076.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. O'Neill L, Holbrook NJ, Fargnoli J, Lakatta EG. Progressive changes from young adult age to senescence in mRNA for rat cardiac myosin heavy chain genes. Cardioscience. 1991;2:1-5.
23. Prophet Statistics. Cambridge, Mass: BBN Systems and Technologies; 1988.
24. Saragoca MA, Tarazi RC. Left ventricular hypertrophy in rats with renovascular hypertension: alterations in cardiac function and adrenergic responses. Hypertension. 1981;3(suppl III):II-171-II-6.
25. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR. Assessment of the β-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986;74:1290-1302.
26. Calderone A, Bouvier M, Li K, Juneau C, de Champlain J, Rouleau JL. Dysfunction of the β- and α-adrenergic systems in a model of congestive heart failure: the pacing-overdrive dog. Circ Res. 1991;69:332-343.
27. Litwin SE, Morgan JP. Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure. Circ Res. 1992;71:797-807.
28. 2+ in myocytes from aortic-banded rats. Circulation. 1996;94:2915-2922.
29. Takeda N, Ohkubo T, Nakamura I, Suzuki H, Nagano M. Mechanical catecholamine responsiveness and myosin isoenzyme pattern of pressure-overloaded rat ventricular myocardium. Basic Res Cardiol. 1987;82:370-374.
30. Rüegg JC. Towards a molecular understanding of contractility. Cardioscience. 1990;1:163-168.
31. Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG. 8-Bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
32. Winegrad S, Weisberg A. Isozyme specific modification of myosin ATPase by cAMP in rat heart. Circ Res. 1987;60:384-392.
33. Hoh JF, Rossmanith GH, Kwan LJ, Hamilton AM. Adrenaline increases the rate of cycling of crossbridges in rat cardiac muscle as measured by pseudo-random binary noise-modulated perturbation analysis. Circ Res. 1988;62:452-461.
34. Winegrad S, McClellan G, Tucker M, Lin LE. Cyclic AMP regulation of myosin isozymes in mammalian cardiac muscle. J Gen Physiol. 1983;81: 749-765.
35. Stuver TP, Cove CJ, Hood WB Jr. Mechanical abnormalities in the rat ischemic heart failure model which lie downstream to cAMP production. J Mol Cell Cardiol. 1994;26:1221-1226.
36. Linden J, Brooker G. Sodium requirement for the positive inotropic action of isoproterenol on guinea pig atria. Science. 1978;199:539-541.
37. Litwin SE, Li J, Bridge JH. Na-Ca exchange and the trigger for sarcoplasmic reticulum Ca release: studies in adult rabbit ventricular myocytes. Biophys J. 1998;75:359-371.
38. 2+ exchanger by phenylephrine, angiotensin II and endothelin 1. J Mol Cell Cardiol. 1996;28: 11-17.